RecruitingNot ApplicableNCT07053969

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness. A Randomized Controlled Trial.


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

32 participants

Start Date

Aug 31, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.


Eligibility

Min Age: 18 YearsMax Age: 18 Years

Inclusion Criteria5

  • Ability of subject to understand and the willingness to sign a written informed consent document.
  • Males and females; Age 18 to 89 years old
  • Require second stage implant uncovering
  • In either the maxillary or mandibular arch
  • Has consistent transportation for all clinical and study visits

Exclusion Criteria5

  • Pregnancy, or those planning to become pregnant
  • Allergy or any medical issue using EMD
  • Non-English speaking
  • Patients on anticoagulants
  • Patients who object to the use of animal products

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEnamel Matrix Derivative

EMD is an FDA approved medical device used in periodontal procedures since 1996. It has been shown to enhance soft and hard tissue healing, increased root coverage and aid in periodontal regeneration. It's use as an adjunct during implant uncovering may increase peri-implant mucosal thickness.


Locations(1)

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07053969


Related Trials